The Yale Liver Research Core Center brings together a multidisciplinary group of 27 independent principal investigators as well as additional professional supporting personnel in the departments of Medicine, Pathology, Pediatrics, Diagnostic Radiology, Laboratory Medicine, Cellular and Molecular Physiology, Human Genetics, and Cell biology at the School of Medicine in order to further the study of liver structure, function and disease. The Center focuses on six major themes: 1) Cellular and molecular biology of the hepatocyte; 2) hepatic transport; 3) hepatic metabolic function; 4) hepatic fibrogenesis; 5) splanchnic hemodynamics; and 6) clinical studies of hepatic disorders. The research activities of the Center are broad and range from fundamental studies of the biology of the hepatocyte to immediate clinical relevancy in the evalution of chronic human liver disease. The principal goals of this Center have been to: 1) stimulate multidisciplinary interactions; 2) provide a rich training environment; 3) foster national and international collaborations; 4) efficiently organize time consuming, more costly techniques and procedures and core facilities for multiple use; 5) to stimulate basic scientists to become more involved in one or more of the Center's areas of research interest; 6) to capitalize on important new research opportunities through pilot feasibility projects, and 7) to create an institutional environment to greatly amplify progress and answer problems in this important area of digestive disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK034989-07
Application #
3102083
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Project Start
1984-09-30
Project End
1994-08-31
Budget Start
1990-09-01
Budget End
1991-08-31
Support Year
7
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Yale University
Department
Type
Schools of Medicine
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520
Pan, Qiong; Zhang, Xiaoxun; Zhang, Liangjun et al. (2018) Solute Carrier Organic Anion Transporter Family Member 3A1 Is a Bile Acid Efflux Transporter in Cholestasis. Gastroenterology 155:1578-1592.e16
Jakab, Sofia Simona; Garcia-Tsao, Guadalupe (2018) Screening and Surveillance of Varices in Patients With Cirrhosis. Clin Gastroenterol Hepatol :
Fiorotto, Romina; Amenduni, Mariangela; Mariotti, Valeria et al. (2018) Src kinase inhibition reduces inflammatory and cytoskeletal changes in ?F508 human cholangiocytes and improves cystic fibrosis transmembrane conductance regulator correctors efficacy. Hepatology 67:972-988
Sari, Sinan; Dalgic, Buket; Muehlenbachs, Atis et al. (2018) Prototheca zopfii Colitis in Inherited CARD9 Deficiency. J Infect Dis 218:485-489
Yu, Dongke; Cai, Shi-Ying; Mennone, Albert et al. (2018) Cenicriviroc, a cytokine receptor antagonist, potentiates all-trans retinoic acid in reducing liver injury in cholestatic rodents. Liver Int 38:1128-1138
Garcia-Tsao, Guadalupe (2018) Regression of HCV cirrhosis: Time will tell. Hepatology 67:1651-1653
Hung, Adelina; Garcia-Tsao, Guadalupe (2018) Acute kidney injury, but not sepsis, is associated with higher procedure-related bleeding in patients with decompensated cirrhosis. Liver Int 38:1437-1441
Kaffe, Eleanna; Fiorotto, Romina; Pellegrino, Francesca et al. (2018) ?-Catenin and interleukin-1?-dependent chemokine (C-X-C motif) ligand 10 production drives progression of disease in a mouse model of congenital hepatic fibrosis. Hepatology 67:1903-1919
Goldberg, David S; Levy, Cynthia; Yimam, Kidist et al. (2018) Primary Sclerosing Cholangitis Is Not Rare Among Blacks in a Multicenter North American Consortium. Clin Gastroenterol Hepatol 16:591-593
Cadamuro, Massimiliano; Stecca, Tommaso; Brivio, Simone et al. (2018) The deleterious interplay between tumor epithelia and stroma in cholangiocarcinoma. Biochim Biophys Acta Mol Basis Dis 1864:1435-1443

Showing the most recent 10 out of 763 publications